Because TGF-β1 is one of the most potent activators of lung fibrosis [9,10], we determined that derrone inhibits the TGF-β-dependent Smad signaling pathway using SBE-luciferase activity and phosphorylation of Smad2 and Smad3. Here, SMAD3 is linked to pulmonary fibrosis.